Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: A superfusion study

Journal of Neurochemistry

Volumn 74, Issue 3, 2000, Pages 1317-1324

  Sitte, H H ^a   Scholze, P ^a   Schloss, P ^b   Pifl, C ^a   Singer, E A ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Efflux; MPP+; Ouabain; Rat serotonin transporter; Superfusion; Uptake

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3,4 METHYLENEDIOXYAMPHETAMINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; CHLORAMPHETAMINE; CITALOPRAM; IMIPRAMINE; OUABAIN; POTASSIUM; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SEROTONIN METABOLISM; SEROTONIN RELEASE; SEROTONIN UPTAKE;

STROPHANTHUS GRATUS;

EID: 0033953794     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.741317.x     Document Type: Article

References (23)

1. Barker E. L. and Blakely R. D. (1996) Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol. Pharmacol. 50, 957-965.
2. Barker E. L., Kimmel H. L., and Blakely R. D. (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol 46, 799-807.
3. Blakely R. D., Ramamoorthy S., Qian Y., Schroeter S., and Bradley C. C. (1997) Regulation of antidepressant-sensitive serotonin transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith M. E. A., ed), pp. 29-73. Humana Press, Totowa, New Jersey.
4. Bönisch H. (1986) The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn Schmiedebergs Arch. Pharmacol. 332, 35-141.
5. Chen N. and Justice J. B. (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport. J. Neurosci 18, 10257-10268.
6. Chen N., Trowbridge C. G., and Justice J. B. Jr. (1998) Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter. J. Neurochem. 71, 653-665.
7. Cinquanta M., Ralovitski T., Crespi D., Gobbi M., Mennini T., and Simantov R. (1997) Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter. Neuropharmacology 36, 803-809.
8. Collard K. J., Cassidy D. M., Pye M. A., and Taylor R. M. (1981) The stimulus-induced release of unmetabolized 5-hydroxytryptamine from supervised rat brain synaptosomes. J. Neurosci. Methods 4, 163-179.
9. Fuller R. W., Hines C. W., and Mills, J. (1965) Lowering of rat brain serotonin levels by chloroamphetamines. Biochem. Pharmacol. 14, 483-488.
10. 3H]serotonin. Naunyn Schmiedebergs Arch. Pharmacol. 345, 1-6.
11. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur. J. Pharmacol. 238, 9-17.
12. 3H]Substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Synapse 30, 97-106.
13. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem. Pharmacol. 31, 983-992.
14. McPherson G. A. (1985) Computer-assisted analysis of complex concentration-response data. J. Pharmacol. Methods 13, 125-134.
15. Pifl C., Drobny H., Reimer H., Hornykiewicz O., and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368-373.
16. Raiteri M., Angelini F., and Levi G. (1974) A simple apparatus for studying the release of neurolransmitters from synaptosomes. Eur. J. Pharmacol. 25, 411-414.
17. Raiteri M., Cerrito F., Cervoni A. M., Del Carmine R., Ribera M. T., and Levi G. (1978) Release of dopamine from striatal synaptosomes. Ann. Ist. Super. Sanita 14, 97-110.
18. Raiteri M., Bonanno G., Marchi M., and Maura G. (1984) Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J. Pharmacol. Exp. Ther. 231, 671-677.
19. Rudnick G. (1997) Mechanism of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith M. E. A., ed), pp. 73-100. Humana Press, Totowa, New Jersey.
20. Rudnick G. and Wall S. C. (1992a) p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31, 6710-6718.
21. Rudnick G. and Wall S. C. (1992b) The molecular mechanism of "ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89, 1817-1821.
22. Sur C., Betz H., and Schloss P. (1998) Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1. J. Neurochem. 70, 2545-2553.
23. Wölfel R. and Graefe K. H. (1992) Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter. Naunyn Schmiedebergs Arch. Pharmacol. 345, 129-136.